Oral Finasteride (5 mg and 2 mg) versus Topical Minoxidil 5% in Female Pattern Hair Loss
Background: Female pattern hair loss (FPHL) has a negative psychological and social impact. Lacks of consensus for its treatment as well as inconsistent response to treatment modalities are considered major challenges for physicians. Objectives: To assess the safety and efficacy of oral finasteride...
Saved in:
Main Authors: | Eman Hamed El Morsy, Asmaa Saad Abd Toto, Eman Mohamed Hassan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
Series: | Clinical Dermatology Review |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/cdr.cdr_87_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low-dose oral minoxidil in a case of short anagen syndrome
by: Divija Sharma, et al.
Published: (2025-12-01) -
Effectiveness of autologous growth factor concentrates combined with topical minoxidil in patients of androgenic alopecia
by: Lavanya Maripati, et al.
Published: (2025-01-01) -
The role of lipids in promoting hair growth through HIF-1 signaling pathway
by: Jieun Seo, et al.
Published: (2025-02-01) -
Progress on mitochondria and hair follicle development in androgenetic alopecia: relationships and therapeutic perspectives
by: Ting-ru Dong, et al.
Published: (2025-02-01) -
Change in hair growth-related gene expression profile in human isolated hair follicles induced by 5-alpha reductase inhibitors – dutasteride and finasteride – in the presence of testosterone
by: Toshiki Hatanaka, et al.
Published: (2022-09-01)